Androgen Deprivation Therapy Market Report 2026
Androgen Deprivation Therapy Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Androgen Deprivation Therapy Market Report 2026

Global Outlook – By Type (Medicine, Surgery, Other Types), By Route Of Administration (Injectable, Oral), By Patient Demographics (Men Aged 40-60, Men Aged 61-75, Men Above 75), By Application (Prostate Cancer, Other Applications), By End-User (Hospitals, Specialty Clinics, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Androgen Deprivation Therapy Market Overview

• Androgen Deprivation Therapy market size has reached to $8.31 billion in 2025

• Expected to grow to $11.1 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%

• Growth Driver: Rising Prostate Cancer Cases Fueling The Growth Of The Market Due To Increasing Aging Population

• Market Trend: Advancements In Oral Androgen Receptor Inhibitor Therapies Improve Treatment Convenience And Outcomes In Prostate Cancer

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Androgen Deprivation Therapy Market?

Androgen deprivation therapy is a treatment method that reduces or suppresses the activity of male hormones in the body to limit the growth of hormone-dependent cells. These hormones play a crucial role in various physiological processes, and lowering their presence can significantly influence cellular functions and biological responses.

The main types of androgen deprivation therapy include medicine, surgery, and others. Medicine in ADT involves the use of drugs to reduce or block the production of androgens. It offers different routes of administration, including injectable and oral, and is used for various patient demographics, such as men aged 40-60, men aged 61-75, and men above 75. It is applied for prostate cancer and others by several end-users, including hospitals, specialty clinics, and others.

Androgen Deprivation Therapy Market Global Report 2026 Market Report bar graph

What Is The Androgen Deprivation Therapy Market Size and Share 2026?

The androgen deprivation therapy market size has grown strongly in recent years. It will grow from $8.31 billion in 2025 to $8.83 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to limited treatment options for prostate cancer, reliance on conventional surgery, slow adoption of injectable therapies, low patient awareness of androgen deprivation therapy, restricted availability of advanced therapies.

What Is The Androgen Deprivation Therapy Market Growth Forecast?

The androgen deprivation therapy market size is expected to see strong growth in the next few years. It will grow to $11.1 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to development of novel anti-androgen drugs, increasing investment in gene and immunotherapies, rising geriatric male population, growth in specialty clinics and hospital oncology departments, integration of digital monitoring and telehealth solutions. Major trends in the forecast period include rising adoption of lhrh agonists and antagonists, increased use of combination and targeted therapies, expansion of minimally invasive surgical procedures, growing focus on patient-specific and age-based treatments, enhanced monitoring and follow-up care for prostate cancer patients.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Androgen Deprivation Therapy Market Segmentation

1) By Type: Medicine, Surgery, Other Types

2) By Route Of Administration: Injectable, Oral

3) By Patient Demographics: Men Aged 40-60, Men Aged 61-75, Men Above 75

4) By Application: Prostate Cancer, Other Applications

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Medicine: LHRH Agonists, LHRH Antagonists, Anti-Androgens, CYP17 Inhibitors, Steroidal Anti-Androgens, Non-Steroidal Anti-Androgens, Estrogen-Based Therapies, Combination Therapies

2) By Surgery: Bilateral Orchiectomy, Subcapsular Orchiectomy, Simple Orchiectomy

3) By Other Types: Radiopharmaceutical Therapy, Gene Therapy, Immunotherapy, Targeted Therapy, Cryotherapy, High-Intensity Focused Ultrasound (HIFU

What Is The Driver Of The Androgen Deprivation Therapy Market?

The increasing incidence of prostate cancer is expected to fuel the growth of the androgen deprivation therapy market in the coming years. Prostate cancer originates in the prostate gland, a part of the male reproductive system responsible for producing seminal fluid. Its incidence is climbing mainly due to longer life spans, as older age significantly raises the risk of developing the disease. Androgen deprivation therapy (ADT) is a primary treatment modality for prostate cancer, aimed at lowering androgen levels that drive tumor growth. It is frequently utilized in advanced or metastatic stages to delay disease progression. For instance, in January 2025, according to a report published by Prostate Cancer UK, a UK-based prostate cancer research, awareness, and support organization, in England, the number of prostate cancer diagnoses increased from 50,751 cases in 2022 to 55,033 cases in 2023, indicating a clear rise in annual incidence. Therefore, the increasing incidence of prostate cancer is driving the growth of the androgen deprivation therapy industry.

Key Players In The Global Androgen Deprivation Therapy Market

Major companies operating in the androgen deprivation therapy market are Johnson & Johnson Services Inc., Astellas Pharma Inc., Ipsen S.A., Ferring Pharmaceuticals SA, Tolmar Pharmaceuticals Inc., Pfizer Inc., Novartis AG, Dr. Reddy's Laboratories Ltd., Orion Corporation, Besins Healthcare S.A., Veru Inc., Kintor Pharmaceutical Limited, Foresee Pharmaceuticals Co. Ltd., Lawley Pharmaceuticals Pty Ltd., AbbVie Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Cipla Ltd., Accord Healthcare Ltd., Mylan N.V. (Viatris), Zydus Lifesciences Ltd., Apotex Inc., Amneal Pharmaceuticals LLC, Glenmark Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Alvogen Inc., BCN Peptides SA, Chugai Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd.

Global Androgen Deprivation Therapy Market Trends and Insights

Major companies operating in the androgen deprivation therapy (ADT) market are focusing on developing advanced solutions, such as oral androgen receptor inhibitors (ARIs), to provide more convenient, tolerable, and effective treatment options for patients with prostate cancer. Oral ARIs are targeted therapies that directly block androgen receptor activity in prostate cancer cells, preventing tumor growth without requiring frequent clinic-administered hormone-suppressing injections. For instance, in June 2025, Bayer AG, a Germany-based multinational pharmaceutical company, received US Food and Drug Administration (FDA) approval for Nubeqa (darolutamide), an oral ARI used in combination with ADT for treating metastatic hormone-sensitive prostate cancer (mHSPC). Designed to improve clinical outcomes and patient quality of life, Nubeqa inhibits androgen receptor signaling with high binding affinity, demonstrates minimal blood–brain barrier penetration to limit central nervous system side effects, and showed a 46% reduction in the risk of radiological progression or death compared to placebo plus ADT, according to the Phase III ARANOTE trial.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Androgen Deprivation Therapy Market?

In February 2025, Tempus, a US-based health technology company, partnered with Artera to bring Artera’s advanced prostate cancer risk assessment test, ArteraAI Prostate Test, to market. This collaboration aims to enhance the accuracy of cancer prognosis by using artificial intelligence to support more informed medical decisions. As a result, ArteraAI's advanced digital pathology test, included in the NCCN guidelines, will assist in identifying patients with intermediate localized prostate cancer who are more likely to benefit from short-term androgen deprivation therapy. Artera is a US-based digital health company.

Regional Insights

North America was the largest region in the androgen deprivation therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Androgen Deprivation Therapy Market?

The androgen deprivation therapy market consists of revenues earned by entities by providing services such as hormonal assessment, monitoring services, telehealth consultations, and diagnosis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The androgen deprivation therapy market also includes sales of hormone monitoring test kits, implantable hormone delivery systems, topical hormone regulation products, and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Androgen Deprivation Therapy Market Report 2026?

The androgen deprivation therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the androgen deprivation therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Androgen Deprivation Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $8.83 billion
Revenue Forecast In 2035 $11.1 billion
Growth Rate CAGR of 6.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Route Of Administration, Patient Demographics, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Johnson & Johnson Services Inc., Astellas Pharma Inc., Ipsen S.A., Ferring Pharmaceuticals SA, Tolmar Pharmaceuticals Inc., Pfizer Inc., Novartis AG, Dr. Reddy's Laboratories Ltd., Orion Corporation, Besins Healthcare S.A., Veru Inc., Kintor Pharmaceutic
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Androgen Deprivation Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Androgen Deprivation Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Androgen Deprivation Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Androgen Deprivation Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Lhrh Agonists And Antagonists

4.2.2 Increased Use Of Combination And Targeted Therapies

4.2.3 Expansion Of Minimally Invasive Surgical Procedures

4.2.4 Growing Focus On Patient-Specific And Age-Based Treatments

4.2.5 Enhanced Monitoring And Follow-Up Care For Prostate Cancer Patients

5. Androgen Deprivation Therapy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Oncology Centers

5.4 Research And Clinical Laboratories

5.5 Pharmaceutical Companies

6. Androgen Deprivation Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Androgen Deprivation Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Androgen Deprivation Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Androgen Deprivation Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Androgen Deprivation Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Androgen Deprivation Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Androgen Deprivation Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Androgen Deprivation Therapy Market Segmentation

9.1. Global Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medicine, Surgery, Other Types

9.2. Global Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable, Oral

9.3. Global Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Men Aged 40-60, Men Aged 61-75, Men Above 75

9.4. Global Androgen Deprivation Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prostate Cancer, Other Applications

9.5. Global Androgen Deprivation Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Other End-Users

9.6. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Medicine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

LHRH Agonists, LHRH Antagonists, Anti-Androgens, CYP17 Inhibitors, Steroidal Anti-Androgens, Non-Steroidal Anti-Androgens, Estrogen-Based Therapies, Combination Therapies

9.7. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bilateral Orchiectomy, Subcapsular Orchiectomy, Simple Orchiectomy

9.8. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Radiopharmaceutical Therapy, Gene Therapy, Immunotherapy, Targeted Therapy, Cryotherapy, High-Intensity Focused Ultrasound (HIFU)

10. Androgen Deprivation Therapy Market Regional And Country Analysis

10.1. Global Androgen Deprivation Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Androgen Deprivation Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Androgen Deprivation Therapy Market

11.1. Asia-Pacific Androgen Deprivation Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Androgen Deprivation Therapy Market

12.1. China Androgen Deprivation Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Androgen Deprivation Therapy Market

13.1. India Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Androgen Deprivation Therapy Market

14.1. Japan Androgen Deprivation Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Androgen Deprivation Therapy Market

15.1. Australia Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Androgen Deprivation Therapy Market

16.1. Indonesia Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Androgen Deprivation Therapy Market

17.1. South Korea Androgen Deprivation Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Androgen Deprivation Therapy Market

18.1. Taiwan Androgen Deprivation Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Androgen Deprivation Therapy Market

19.1. South East Asia Androgen Deprivation Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Androgen Deprivation Therapy Market

20.1. Western Europe Androgen Deprivation Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Androgen Deprivation Therapy Market

21.1. UK Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Androgen Deprivation Therapy Market

22.1. Germany Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Androgen Deprivation Therapy Market

23.1. France Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Androgen Deprivation Therapy Market

24.1. Italy Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Androgen Deprivation Therapy Market

25.1. Spain Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Androgen Deprivation Therapy Market

26.1. Eastern Europe Androgen Deprivation Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Androgen Deprivation Therapy Market

27.1. Russia Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Androgen Deprivation Therapy Market

28.1. North America Androgen Deprivation Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Androgen Deprivation Therapy Market

29.1. USA Androgen Deprivation Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Androgen Deprivation Therapy Market

30.1. Canada Androgen Deprivation Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Androgen Deprivation Therapy Market

31.1. South America Androgen Deprivation Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Androgen Deprivation Therapy Market

32.1. Brazil Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Androgen Deprivation Therapy Market

33.1. Middle East Androgen Deprivation Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Androgen Deprivation Therapy Market

34.1. Africa Androgen Deprivation Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Androgen Deprivation Therapy Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Androgen Deprivation Therapy Market Regulatory and Investment Landscape

36. Androgen Deprivation Therapy Market Competitive Landscape And Company Profiles

36.1. Androgen Deprivation Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Androgen Deprivation Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Androgen Deprivation Therapy Market Company Profiles

36.3.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Ipsen S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Ferring Pharmaceuticals SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Tolmar Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Androgen Deprivation Therapy Market Other Major And Innovative Companies

Pfizer Inc., Novartis AG, Dr. Reddy's Laboratories Ltd., Orion Corporation, Besins Healthcare S.A., Veru Inc., Kintor Pharmaceutical Limited, Foresee Pharmaceuticals Co. Ltd., Lawley Pharmaceuticals Pty Ltd., AbbVie Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Lupin Limited

38. Global Androgen Deprivation Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Androgen Deprivation Therapy Market

40. Androgen Deprivation Therapy Market High Potential Countries, Segments and Strategies

40.1 Androgen Deprivation Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Androgen Deprivation Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Androgen Deprivation Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Androgen Deprivation Therapy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Androgen Deprivation Therapy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Androgen Deprivation Therapy Market, Supply Chain Analysis
  • Table 4: Global Androgen Deprivation Therapy Market, Major Raw Material Providers
  • Table 5: Global Androgen Deprivation Therapy Market, Major Resource Providers
  • Table 6: Global Androgen Deprivation Therapy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Androgen Deprivation Therapy Market, Major Distributors And Channel Partners
  • Table 8: Global Androgen Deprivation Therapy Market, Key Technologies & Future Trends
  • Table 9: Global Androgen Deprivation Therapy Market, Major Trends
  • Table 10: Global Androgen Deprivation Therapy Market, Major End Users
  • Table 11: Global Androgen Deprivation Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Androgen Deprivation Therapy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Androgen Deprivation Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Androgen Deprivation Therapy Market - TAM, US$ Billion, 2025
  • Table 15: Global Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Androgen Deprivation Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Androgen Deprivation Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Medicine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Androgen Deprivation Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Androgen Deprivation Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Androgen Deprivation Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Androgen Deprivation Therapy Market - Company Scoring Matrix
  • Table 99: Johnson & Johnson Services Inc. Financial Performance
  • Table 100: Astellas Pharma Inc. Financial Performance
  • Table 101: Ipsen S.A. Financial Performance
  • Table 102: Ferring Pharmaceuticals SA Financial Performance
  • Table 103: Tolmar Pharmaceuticals Inc. Financial Performance
  • Table 104: Global Androgen Deprivation Therapy Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Androgen Deprivation Therapy Market, Competitive Dashboard
  • Table 106: Global Androgen Deprivation Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Androgen Deprivation Therapy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 108: Global, Androgen Deprivation Therapy Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 109: Global, Androgen Deprivation Therapy Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

List Of Figures

    Figure 1: Global Androgen Deprivation Therapy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Androgen Deprivation Therapy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Androgen Deprivation Therapy Market, Supply Chain Analysis
  • Figure 4: Global Androgen Deprivation Therapy Market, Major Raw Material Providers
  • Figure 5: Global Androgen Deprivation Therapy Market, Major Resource Providers
  • Figure 6: Global Androgen Deprivation Therapy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Androgen Deprivation Therapy Market, Major Distributors And Channel Partners
  • Figure 8: Global Androgen Deprivation Therapy Market, Key Technologies & Future Trends
  • Figure 9: Global Androgen Deprivation Therapy Market, Major Trends
  • Figure 10: Global Androgen Deprivation Therapy Market, Major End Users
  • Figure 11: Global Androgen Deprivation Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Androgen Deprivation Therapy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Androgen Deprivation Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Androgen Deprivation Therapy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Androgen Deprivation Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Androgen Deprivation Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Medicine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Androgen Deprivation Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Androgen Deprivation Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Androgen Deprivation Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Androgen Deprivation Therapy Market - Company Scoring Matrix
  • Figure 99: Johnson & Johnson Services Inc. Financial Performance
  • Figure 100: Astellas Pharma Inc. Financial Performance
  • Figure 101: Ipsen S.A. Financial Performance
  • Figure 102: Ferring Pharmaceuticals SA Financial Performance
  • Figure 103: Tolmar Pharmaceuticals Inc. Financial Performance
  • Figure 104: Global Androgen Deprivation Therapy Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Androgen Deprivation Therapy Market, Competitive Dashboard
  • Figure 106: Global Androgen Deprivation Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Androgen Deprivation Therapy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 108: Global, Androgen Deprivation Therapy Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 109: Global, Androgen Deprivation Therapy Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Frequently Asked Questions

The Androgen Deprivation Therapy market was valued at $8.31 billion in 2025, increased to $8.83 billion in 2026, and is projected to reach $11.1 billion by 2030.

The global Androgen Deprivation Therapy market is expected to grow at a CAGR of 5.9% from 2026 to 2035 to reach $11.1 billion by 2035.

Some Key Players in the Androgen Deprivation Therapy market Include, Johnson & Johnson Services Inc., Astellas Pharma Inc., Ipsen S.A., Ferring Pharmaceuticals SA, Tolmar Pharmaceuticals Inc., Pfizer Inc., Novartis AG, Dr. Reddy's Laboratories Ltd., Orion Corporation, Besins Healthcare S.A., Veru Inc., Kintor Pharmaceutical Limited, Foresee Pharmaceuticals Co. Ltd., Lawley Pharmaceuticals Pty Ltd., AbbVie Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Cipla Ltd., Accord Healthcare Ltd., Mylan N.V. (Viatris), Zydus Lifesciences Ltd., Apotex Inc., Amneal Pharmaceuticals LLC, Glenmark Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Alvogen Inc., BCN Peptides SA, Chugai Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd. .

Major trend in this market includes: Advancements In Oral Androgen Receptor Inhibitor Therapies Improve Treatment Convenience And Outcomes In Prostate Cancer . For further insights on this market. request a sample here

North America was the largest region in the androgen deprivation therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgen deprivation therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts